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Objective: Reconstitution of dendritic cells (DC) and lymphocytes
is critical for protective immunity, however, the tempo of their re-
covery is variable and their impact at specific time points on UCBT
outcome is not defined. This study aims to analyze the impact of
cellular immune reconstitution within the first year.
Methods: Between 07/05 and 12/07, 93 children with full donor
chimerism following myeloablative conditioning were longitudi-
nally assessed at Day (D) 100, 180, 270 and 365 for reconstitution
of DC and T cell subsets, B and NK cells by 4 color FACS to
determine thresholds associated with overall survival (OS).
Parameters were dichotomized at the median (M) of each time
point and hazard ratios estimated by Cox proportional hazards
analysis.
Results: Patients were transplanted for non-malignant (N 5 63)
and malignant diseases (N 5 30). M age was 2.1 years, 58%
male, 36% were 4/6, 42% were 5/6 and 23% were 6/6 HLA
matched. The M infused TNC and CD341 cell dose was
7.3x107/kg and 1.9x105/kg, respectively. 22 patients died within 2
years: OS at 2-years 76%. At D100, lower percentage and abso-
lute numbers of regulatory T cells (CD251/CD62L1/
CD41Tregs) was associated with death (p 5 0.04 and p 5 0.02).
A higher fraction of ‘‘activated’’ HLA-DR expressing CD81 T
cells predicted death at D100 with marginal significance at 180
and 270 while absolute numbers significant at D270. At D180, a pe-
riod when thymic function may resume, a rise in ‘recent thymic
emigrants’ was associated with survival (RTE, CD45RA1/
CD62L1 T cells), p 5 0.01 and p 5 0.04. Higher levels of ‘plas-
macytoid’ CD1231 DC were consistently associated with better
OS after D100 (p \ 0.05). Major lymphocyte subsets, B, NK,
CD31, CD41 T cells were NOT associated with superior OS ex-
cept at D180 with all lymphocytes combined, exceeding an ALC of
. 1180/ul (p 5 0.04). Table 1 depicts the Hazard Ratios for the
above immune parameters with cut-offs at the median values.
Conclusions: Our data demonstrate that different immune cells
will have unique kinetics and dynamics of recovery that confer
shifting power in predicting outcome at different time points
within the first year. Nevertheless, by the second half of the first
year, superior pDC and RTE recovery along with a reduced activa-
tion state (%HLA-DR) are independently associated with better
OS. These results should facilitate the development of risk models
for the early identification of those at highest risk of death and who
may benefit from novel immunotherapies.
Table 1. Cellular Factors of Immune Reconstitution Associ-
ated with Death After UCBT
TimeParameterPoint
(Day)Cut -Off
Level Hazard Ratio P- ValueAbsolute Lymphocyte
Count /ul180 # 1180 1.0000180 > 1180 0.3175 (0.1052-0.958) 0.0417CD45RA+ /62L+ (RTE)
(% of CD3+)180 # 7 1.0000180 > 7 0.2403 (0.079-0.7308) 0.012CD45RA+ / CD62L+
(RTE) (% CD4+)180 # 4 1.0000(Continued )Table 1. (Continued )ParameterTime
Point
(Day)Cut -Off
Level Hazard Ratio P- Value180 > 4 0.343 (0.1222-0.9628) 0.0422CD25+ /CD62L+ (T-Reg)
(% of CD4+)100 # 22.5 1.0000100 >22.5 0.3337 (0.1186-0.9385) 0.0375Absolute Number of CD25+
/CD62L+/CD4+ T-Reg/ul100 # 23 1.0000100 > 23 0.252 (0.0828-0.767) 0.0152HLA-DR+ (Activated)
(% of CD8+)100 # 46.5 1.0000100 > 46.5 4.3873 (1.4253-13.5047) 0.0099180 # 29.0 1.0000180 > 29.0 2.5483 (0.9553-6.7973) 0.0617270 # 15 1.0000270 > 15 3.215 (0.8527-12.1217) 0.0846Absolute Number of HLA-
DR+ /CD8+ T cells/ul270 # 11.9 1.0000270 > 11.9 5.0176 (1.0837-23.2329) 0.0391Absolute Number of CD123+
(pDC) (Cells / ul)180 # 7.5 1.0000180 > 7.5 0.3394 (0.1207-0.9545) 0.0405270 # 6.7 1.0000270 # 6.7 0.2063 (0.0446-0.9552) 0.0435365 # 8.2 1.0000365 > 8.2 0.0862 (0.011-0.6758) 0.0197Hazard Ratio’s and ( p-values) at each time point207
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Background:Tounderstand the pathogenesis of allogeneic immune
reaction early after cord blood transplantation (CBT), we analyzed
the kinetics of donor-chimerism and T-cell phenotype during early
period after CBT.
Methods: Analysis of chimerism was performed on CD3, CD4,
CD8, andCD56 fractions of peripheral blood byHLA-Flowmethod
on 1, 2, 3, 4, and 8 weeks after CBT. T-cell phenotype was analyzed
by flow-cytometry on 2, 4, and 8 weeks after CBT in engrafted
patients.
Results: Forty-eight patients were enrolled in this study. The pa-
tients had a median age of 57.5 years (range, 19-71 years). All except
for two patients received fludarabine-based conditioning. GVHD
prophylaxis was mainly composed of tacrolimus and mycophenolate
mofetil (n 5 35). Forty-one patients achieved neutrophil engraft-
ment at a median of 20 days (range, 13-44 days). Using HLA-Flow
method for the chimerism analysis (n 5 32), the engrafted patients
(n 5 28) showed rapid switch to donor-type dominant chimerism;
the median percentages of donor-derived CD41 T-cells, CD81 T-
cells and NK cells at one week were 89.8% (range, 19.1-100%),
91.7% (range, 9.3-100%) and 95.3% (range, 23.5-100%), respec-
tively, and all the patients reached complete donor chimerism by 3
weeks. In phenotypical analysis (n 5 42), the proportions of na€ıve
phenotype (CD45RA1 CCR71) in CD41 and CD81 T-cells at 2
weeks decreased rapidly to a median of 55% (range, 10-90%) and
20% (range, 1-88%), respectively.
Conclusions: We observed rapid chimerism-switch of lympho-
cytes along with early T-cell differentiation from na€ıve to mem-
ory phenotype after CBT. These findings may explain the
mechanisms behind severe immune-mediated complications
following CBT.
